ISA Pharmaceuticals to Present at the Biotech Showcase™ Annual Conference 2018

03 Jan 2018

Leiden, The Netherlands, January 3, 2018 – ISA Pharmaceuticals B.V., a clinical-stage immunotherapy company, today announced that it will present at Biotech Showcase™ 2018, to be held January 8–10 at the Hilton San Francisco Union Square.

Ronald Loggers, CEO of ISA Pharmaceuticals, will present at Biotech Showcase™ as follows:

Date: Tuesday, January 9, 2018

Time: 9:45am (PST)

Room: Hilton / Franciscan C, Ballroom Level

Venue: Hilton San Francisco Union Square Hotel, 333 O’Farrell Street, San Francisco, CA (United States)

###

 

About ISA Pharmaceuticals

ISA Pharmaceuticals B.V. is an immunotherapy company developing rationally designed, fully synthetic immunotherapeutics against cancer and persistent viral infections. The company has built a proprietary

Read more »